Centro Oncológico de Mérida

Centro Oncológico de Mérida Centro Oncológico de Merida, es una clínica especializada en la salud y calidad de vida para pacie

Cirugía Oncológica - Quimioterapia
Afiliaciones: ASCO - ESMO - ECCO - FLASCA - SLACOM
Sociedad Mexicana de Oncología - Sociedad de Mastología
Miembro de Consejo Mexicano de Oncología 4a Rectificación 2012
Especialidad en Oncología Quirúrgica

10/03/2025

Cervical cancer is highly preventable and highly curable if caught early. Nearly all cervical cancers could be prevented by HPV vaccination, routine cervical cancer screening, and appropriate follow-up treatment when needed. Learn more about cervical cancer causes, risks factors,
and prevention. https://go.nih.gov/prIezKW

10/03/2025

Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common inherited genetic change that increases the risk of several kinds of cancer, including colorectal cancer. In a recent study, researchers carried out genomic analyses of colon tissues from people with Lynch syndrome, looking for alterations that happened during the initial changes from healthy tissue to developing cancer. https://go.nih.gov/larV7Nb

09/03/2025

Cervical cancer is a slow-developing cancer that starts in the cells of the cervix, or the lower, narrow end of the uterus (womb). Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which abnormal cells begin to appear in the cervical tissue. Over time, if not destroyed or removed, the abnormal cells may become cancer cells and start to grow and spread more deeply into the cervix and to surrounding areas. Learn more: https://go.nih.gov/Vye1W1a

28/02/2025

Bile duct cancer, also called cholangiocarcinoma, is a rare disease in which cancer cells form in the bile ducts. Learn more about this cancer and treatment options: https://go.nih.gov/1yXKqzx

13/12/2024

🎉Check out the Editor's Choice Article "Low-Volume Metastases in Cervical Cancer: Does Size Matter?"

✍by Tommaso Bianchi et al. Università degli Studi di Milano-Bicocca

📌Link here: https://t.ly/pQCws

🔹This review is of importance for clinicians treating early cervical cancer. It gives a complete overview of both prognosis and adjuvant treatment recommendations in patients with early cervical cancer and micrometastases or isolated tumor cells in the sentinel node.🔹

14/11/2024

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of . The NCI-led Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium aims to develop a multidisciplinary community of PDAC researchers that will expand upon traditional tumor-centric studies and ongoing immuno-oncology efforts. Learn more: https://go.nih.gov/EFGzCmL

07/11/2024

Stomach cancer is caused by certain changes to the way stomach cells function, especially how they grow and divide into new cells. Read more about the different types of stomach cancer, also called gastric cancer: https://go.nih.gov/Ddmn1XC

02/11/2024

🎉Check out the Editor's Choice Article "Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer"

🧐by Brittney Shulman Zimmerman and Francisco J. Esteva
Northwell Health

💠I believe that this article would be worth highlighting as it addresses one of the newest and most exciting areas of cancer therapeutics💠

📌Link here: https://t.ly/mE3fZ

27/10/2024

🎉Check out the Editor's Choice Article "Assessing the New 2020 ESGO/ESTRO/ESP Endometrial Cancer Risk Molecular Categorization System for Predicting Survival and Recurrence"

✍by Yung-Taek Ouh et al. Korea University

🔗Link here: https://t.ly/2184U

🔹This study is of importance because it represents a validation of the new ESGO molecular classification for endometrial cancer. Atlhough similar studies have been performed earlier, this study is in agreement with previous studies and therefore of clinical importance.🔹

11/10/2024
06/07/2024

Making treatment more effective for more people is essential

Dirección

Yucatán

Horario de Apertura

Lunes 3pm - 9pm
Martes 3pm - 9pm
Miércoles 3pm - 9pm
Jueves 3pm - 9pm
Viernes 3pm - 9pm
Sábado 9am - 3pm

Teléfono

+529999254814

Página web

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Centro Oncológico de Mérida publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a Centro Oncológico de Mérida:

Compartir

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Categoría